Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.46 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | KDM1A | O60341 | 4/20 | 0.42 |
| ▸ | MAOA | P21397 | 4/20 | 0.42 |
| ▸ | MAOB | P27338 | 4/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | TACR1 | P25103 | 2/20 | 0.41 |
| ▸ | HCRTR2 | O43614 | 3/20 | 0.41 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.41 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAP1LC3B | Q9GZQ8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8073204 | 0.79 | TACR1 (0.46) | SIGMAR1TMEM97TSHRKDM1AMAOA | |
| SCHEMBL5855768 | 0.79 | TSHR (0.41) | TSHRKDM1AMAOBHCRTR2HCRTR1 | |
| SCHEMBL2716432 | 0.79 | ESR2 (0.52) | — | |
| SCHEMBL2730097 | 0.78 | TP53 (0.51) | MAOAMAOBGAAMAPTCYP2C19 | |
| SCHEMBL15630936 | 0.77 | CYP11B2 (0.51) | TRPA1HCRTR2MAPT | |
| SCHEMBL5856089 | 0.77 | HCRTR1 (0.43) | KDM1AHCRTR2HCRTR1MAPTMEN1 | |
| SCHEMBL7787343 | 0.75 | TSHR (0.50) | TSHRKDM1AMAOAMAOBHCRTR2 | |
| SCHEMBL16377614 | 0.75 | TSHR (0.50) | TSHRKDM1AMAOAMAOBHCRTR2 | |
| SCHEMBL5371551 | 0.75 | TSHR (0.50) | TSHRKDM1AMAOAMAOBHCRTR2 | |
| SCHEMBL15791659 | 0.74 | TMEM97 (0.38) | SIGMAR1TMEM97TSHRTRPA1TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210226253-A1 | ELECTROLYTIC SOLUTION FOR LITHIUM-ION SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY | MURATA MANUFACTURING CO., LTD. (JP) | 2021-07-22 | — | — | US | disclosed |
| EP-3370681-A1 | REDOX POLYMERIZABLE DENTAL COMPOSITION WITH PHOTOLABILE TRANSITION METAL COMPLEXES | 3M Innovative Properties Company (US) | 2018-09-12 | — | — | EP | disclosed |
| EP-3370680-A1 | REDOX POLYMERIZABLE COMPOSITION WITH PHOTOLABILE TRANSITION METAL COMPLEXES | 3M Innovative Properties Company (US) | 2018-09-12 | — | — | EP | disclosed |
| WO-2017079189-A1 | REDOX POLYMERIZABLE DENTAL COMPOSITION WITH PHOTOLABILE TRANSITION METAL COMPLEXES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-05-11 | — | — | WO | disclosed |
| WO-2017078883-A1 | REDOX POLYMERIZABLE COMPOSITION WITH PHOTOLABILE TRANSITION METAL COMPLEXES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-05-11 | — | — | WO | disclosed |
| US-5500484-A | FROM ALDEHYDE | KURARAY CO., LTD. (JP) | 1996-03-19 | — | — | US | disclosed |
| EP-0641757-A1 | 2-Aryl-1,3-propanediol and dioxane derivatives and their preparation | KURARAY CO., LTD. (JP) | 1995-03-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210226253-A1 | ELECTROLYTIC SOLUTION FOR LITHIUM-ION SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY | TPO, DNASE1, KCNN2 | SIGMAR1 3698/4885TMEM97 3971/4885TSHR 1943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.